Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Nadali

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Leukemia & Lymphoma|May 7, 1998
Soluble molecules as biological markers in Hodgkin's diseaseG Nadali, F Vinante, M Chilosi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 12, 2002
Multi-resistant idiopathic thrombocytopenia successfully treated by eradication of Helicobacter pyloriE Soldinger, M C Pilia, W Piubello, et al.
International Journal of Clinical & Laboratory Research|January 1, 1995
CD34 cell separation: from basic research to clinical applicationsG Nadali, E A de Wynter, N G Testa
Immunology Today|March 1, 1994
Circulating soluble ICAM-1 in patients with Hodgkin's diseaseG Pizzolo, F Vinante, G Nadali, et al.
Haematologica|July 18, 2000
Intracellular cytokine profile of cord blood T-, and NK- cells and monocytesM Krampera, L Tavecchia, F Benedetti, et al.
Stem Cells (Dayton, Ohio)|September 1, 1996
Extensive amplification of single cells from CD34+ subpopulations in umbilical cord blood and identification of long-term culture-initiating cells present in two subsetsE A de Wynter, G Nadali, L H Coutinho, et al.
Clinical and Experimental Immunology|May 1, 1997
High serum level of soluble CD30 in acute primary HIV-1 infectionG Pizzolo, F Vinante, G Nadali, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 28, 2002
Serum levels of soluble CD30 improve International Prognostic Score in predicting the outcome of advanced Hodgkin's lymphomaR Zanotti, A Trolese, A Ambrosetti, et al.
International Journal of Clinical & Laboratory Research|January 1, 1995
Correlation between clinical features and circulating levels of soluble intercellular adhesion molecule-1 in Hodgkin's diseaseG Nadali, F Vinante, A Rigo, et al.
International Journal of Clinical & Laboratory Research|January 1, 1995
Circulating levels of soluble CD23 reflect clinical and biological features of leukemic B-cell chronic lymphoproliferative disordersF Vinante, A Vassanelli, R Zanotti, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Leukemia & Lymphoma|May 7, 1998
Soluble molecules as biological markers in Hodgkin's diseaseG Nadali, F Vinante, M Chilosi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 12, 2002
Multi-resistant idiopathic thrombocytopenia successfully treated by eradication of Helicobacter pyloriE Soldinger, M C Pilia, W Piubello, et al.
International Journal of Clinical & Laboratory Research|January 1, 1995
CD34 cell separation: from basic research to clinical applicationsG Nadali, E A de Wynter, N G Testa
Immunology Today|March 1, 1994
Circulating soluble ICAM-1 in patients with Hodgkin's diseaseG Pizzolo, F Vinante, G Nadali, et al.
Haematologica|July 18, 2000
Intracellular cytokine profile of cord blood T-, and NK- cells and monocytesM Krampera, L Tavecchia, F Benedetti, et al.
Stem Cells (Dayton, Ohio)|September 1, 1996
Extensive amplification of single cells from CD34+ subpopulations in umbilical cord blood and identification of long-term culture-initiating cells present in two subsetsE A de Wynter, G Nadali, L H Coutinho, et al.
Clinical and Experimental Immunology|May 1, 1997
High serum level of soluble CD30 in acute primary HIV-1 infectionG Pizzolo, F Vinante, G Nadali, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 28, 2002
Serum levels of soluble CD30 improve International Prognostic Score in predicting the outcome of advanced Hodgkin's lymphomaR Zanotti, A Trolese, A Ambrosetti, et al.
International Journal of Clinical & Laboratory Research|January 1, 1995
Correlation between clinical features and circulating levels of soluble intercellular adhesion molecule-1 in Hodgkin's diseaseG Nadali, F Vinante, A Rigo, et al.
International Journal of Clinical & Laboratory Research|January 1, 1995
Circulating levels of soluble CD23 reflect clinical and biological features of leukemic B-cell chronic lymphoproliferative disordersF Vinante, A Vassanelli, R Zanotti, et al.
Pageof 4